Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Nau

Showing results (181-190 of 317) with videos related to

Pageof 32
Sort By:
Epilepsy Research|December 1, 1992
Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. I. Biochemical, histopathological and pharmacokinetic studiesW Löscher, U Wahnschaffe, D Hönack, et al.
Chirality|September 1, 1999
Enantioselective synthesis and teratogenicity of propylisopropyl acetamide, a CNS-active chiral amide analogue of valproic acidO Spiegelstein, M Bialer, M Radatz, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1981
Valproic acid and its metabolites: placental transfer, neonatal pharmacokinetics, transfer via mother's milk and clinical status in neonates of epileptic mothersH Nau, D Rating, S Koch, et al.
Life Sciences|December 28, 1981
A new model for embryotoxicity testing: teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrationsH Nau, R Zierer, H Spielmann, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1995
Metabolism of oral 9-cis-retinoic acid in the human. Identification of 9-cis-retinoyl-beta-glucuronide and 9-cis-4-oxo-retinoyl-beta-glucuronide as urinary metabolitesJ O Sass, E Masgrau, J H Saurat, et al.
Toxicology Letters|August 1, 1989
Transplacental pharmacokinetics and teratogenicity of a single dose of retinol (vitamin A) during organogenesis in the mouseC Eckhoff, B Löfberg, I Chahoud, et al.
Journal of Clinical Pharmacology|March 1, 1988
Pregnancy-specific changes of antipyrine pharmacokinetics correlate inversely with changes of estradiol/progesterone plasma concentration ratiosW Loock, H Nau, M Schmidt-Gollwitzer, et al.
Life Sciences|January 1, 1996
Identification of 9-cis-retinoic acid, 9,13-di-cis-retinoic acid, and 14-hydroxy-4,14-retro-retinol in human plasma after liver consumptionT Arnhold, G Tzimas, W Wittfoht, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 4, 1999
Metabolism of retinaldehyde isomers in pregnant rats: 13-cis- and all-trans-retinaldehyde, but not 9-cis-retinaldehyde, yield very similar patterns of retinoid metabolitesJ O Sass, G Tzimas, M M Elmazar, et al.
Toxicology|May 1, 1986
Predicting the human teratogenic potential of the anticonvulsant, valproic acid, from a non-human primate modelT J Mast, M A Cukierski, H Nau, et al.
Pageof 32

Showing results (181-190 of 317) with videos related to

Sort By:
Pageof 32
Epilepsy Research|December 1, 1992
Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. I. Biochemical, histopathological and pharmacokinetic studiesW Löscher, U Wahnschaffe, D Hönack, et al.
Chirality|September 1, 1999
Enantioselective synthesis and teratogenicity of propylisopropyl acetamide, a CNS-active chiral amide analogue of valproic acidO Spiegelstein, M Bialer, M Radatz, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1981
Valproic acid and its metabolites: placental transfer, neonatal pharmacokinetics, transfer via mother's milk and clinical status in neonates of epileptic mothersH Nau, D Rating, S Koch, et al.
Life Sciences|December 28, 1981
A new model for embryotoxicity testing: teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrationsH Nau, R Zierer, H Spielmann, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1995
Metabolism of oral 9-cis-retinoic acid in the human. Identification of 9-cis-retinoyl-beta-glucuronide and 9-cis-4-oxo-retinoyl-beta-glucuronide as urinary metabolitesJ O Sass, E Masgrau, J H Saurat, et al.
Toxicology Letters|August 1, 1989
Transplacental pharmacokinetics and teratogenicity of a single dose of retinol (vitamin A) during organogenesis in the mouseC Eckhoff, B Löfberg, I Chahoud, et al.
Journal of Clinical Pharmacology|March 1, 1988
Pregnancy-specific changes of antipyrine pharmacokinetics correlate inversely with changes of estradiol/progesterone plasma concentration ratiosW Loock, H Nau, M Schmidt-Gollwitzer, et al.
Life Sciences|January 1, 1996
Identification of 9-cis-retinoic acid, 9,13-di-cis-retinoic acid, and 14-hydroxy-4,14-retro-retinol in human plasma after liver consumptionT Arnhold, G Tzimas, W Wittfoht, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 4, 1999
Metabolism of retinaldehyde isomers in pregnant rats: 13-cis- and all-trans-retinaldehyde, but not 9-cis-retinaldehyde, yield very similar patterns of retinoid metabolitesJ O Sass, G Tzimas, M M Elmazar, et al.
Toxicology|May 1, 1986
Predicting the human teratogenic potential of the anticonvulsant, valproic acid, from a non-human primate modelT J Mast, M A Cukierski, H Nau, et al.
Pageof 32